Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shanghai Pharmtech is a China-based pharmaceutical company focused primarily on veterinary pharmaceuticals and related outsourcing services. Founded in 2002 with investment from Sinopharm International, the company presents itself as a comprehensive supplier across the pharmaceutical value chain, including active pharmaceutical ingredients, finished dosage forms, contract research and development, contract manufacturing, regulatory support, and distribution. Public directory profiles indicate cGMP-oriented manufacturing capabilities and a business emphasis on animal health products rather than a novel human therapeutics pipeline. The company appears to operate as a commercial-stage supplier and service provider, with products and capabilities spanning veterinary APIs, formulations, registration support, and OEM/CDMO services. Based on available evidence, Shanghai Pharmtech is best characterized as an active private veterinary-pharma and pharma services company rather than a clinical-stage biotech innovator.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shanghai Pharmtech.